albuterol has been researched along with Intraventricular Septal Defects in 1 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rex, CE | 1 |
| Eckerström, F | 1 |
| Heiberg, J | 1 |
| Maagaard, M | 1 |
| Rubak, S | 1 |
| Redington, A | 1 |
| Hjortdal, VE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Cardiopulmonary Function in Adults Born With a Ventricular Septal Defect[NCT03684161] | 95 participants (Actual) | Observational | 2018-09-24 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for albuterol and Intraventricular Septal Defects
| Article | Year |
|---|---|
Surgical closure of a ventricular septal defect in early childhood leads to altered pulmonary function in adulthood: A long-term follow-up.
Topics: Administration, Inhalation; Adult; Airway Resistance; Albuterol; Bronchodilator Agents; Cardiac Surg | 2019 |